CincyTech (@cincy_tech) 's Twitter Profile
CincyTech

@cincy_tech

We are a venture capital firm that invests in founders with complex innovations that drive compelling improvements to the world’s critical challenges.

ID: 21137582

linkhttp://cincytechusa.com calendar_today17-02-2009 22:14:30

7,7K Tweet

7,7K Takipçi

1,1K Takip Edilen

CincyTech (@cincy_tech) 's Twitter Profile Photo

More exciting portfolio company news coming your way... TeamCentral has just raised a $3.875M seed round to accelerate enterprise AI readiness and integration automation, marking a major leap forward for businesses looking to harness the power of AI. rochesterfirst.com/business/press…

More exciting portfolio company news coming your way...

TeamCentral has just raised a $3.875M seed round to accelerate enterprise AI readiness and integration automation, marking a major leap forward for businesses looking to harness the power of AI.

rochesterfirst.com/business/press…
Mark Jeffreys (@jeffreysms) 's Twitter Profile Photo

Launched “City as Lab” today. Thx to administration & start-up partners. The video of the AirTrek autonomous vehicle cleaning Lunken airport below is super cool! Cintrifuse CincyTech 1819 Innovation Hub AlloyDevCo fox19.com/2025/05/30/aut…

CincyTech (@cincy_tech) 's Twitter Profile Photo

City as a Lab is LIVE! City as a Lab invites innovators to use Cincinnati as a real-world testing ground for breakthrough tech and life sciences solutions A big thank you to Councilman Mark Jeffreys and the entire StartupCincy ecosystem for bringing this to life.

City as a Lab is LIVE! 

City as a Lab invites innovators to use Cincinnati as a real-world testing ground for breakthrough tech and life sciences solutions

A big thank you to <a href="/ccc_jeffreys/">Councilman Mark Jeffreys</a> and the entire <a href="/StartupCincy/">StartupCincy</a> ecosystem for bringing this to life.
CincyTech (@cincy_tech) 's Twitter Profile Photo

This week, we joined Cincinnati Children's Innovation Ventures for “Unlocking Innovation," a dynamic panel on disclosure, collaboration & capital, accelerating research from lab to market We’re excited to help launch the new Innovation Ventures Office Hours pilot!

This week, we joined <a href="/CincyChildrens/">Cincinnati Children's</a>  Innovation Ventures for “Unlocking Innovation," a dynamic panel on disclosure, collaboration &amp; capital, accelerating research from lab to market

We’re excited to help launch the new Innovation Ventures Office Hours pilot!
CincyTech (@cincy_tech) 's Twitter Profile Photo

Meet our newest interns, Liam, Investment Analyst Intern, and Henry, Accounting Intern! They'll be diving into startup research, valuations, due diligence, and financials and reporting. We're pumped to have them on the CincyTech team!

Meet our newest interns, Liam, Investment Analyst Intern, and Henry, Accounting Intern!

They'll be diving into startup research, valuations, due diligence, and financials and reporting.

We're pumped to have them on the CincyTech team!
CincyTech (@cincy_tech) 's Twitter Profile Photo

We're proud to have 4 CincyTech portfolio companies as finalists at the Cincinnati Inno Awards! 🏆 🔹 Abre – Startup of the Year 🔹 Vixiv – Disruptor 🔹 LISNR – Best Overall Tech 🔹 Genetesis – Health Tech 🎟️ See the winners June 11: bit.ly/3Viy3XO

We're proud to have 4 CincyTech portfolio companies as finalists at the <a href="/CincyInno/">Cincinnati Inno</a> Awards! 🏆

🔹 Abre – Startup of the Year
🔹 Vixiv – Disruptor
🔹 LISNR – Best Overall Tech
🔹 Genetesis – Health Tech

🎟️ See the winners June 11: bit.ly/3Viy3XO
CincyTech (@cincy_tech) 's Twitter Profile Photo

Big wins at the 2025 Cincinnati Inno Fire Awards! 🔥 Congrats to all winners—esp. our portfolio company, Vixiv (Disruptor)! 👏 Shoutout to CincyTech honorees: Abre, LISNR, & Genetesis Cincinnati’s startup momentum is real. 💥 #StartupCincy

Big wins at the 2025 <a href="/CincyInno/">Cincinnati Inno</a>  Fire Awards! 🔥
Congrats to all winners—esp. our portfolio company, Vixiv (Disruptor)!

👏 Shoutout to CincyTech honorees: Abre, <a href="/lisnr/">LISNR</a>, &amp; <a href="/GenetesisInc/">Genetesis</a> 

Cincinnati’s startup momentum is real. 💥 #StartupCincy
CincyTech (@cincy_tech) 's Twitter Profile Photo

🚨 Progress update from Clarametyx Biosciences! CMTX-101 for CF lung infections moves forward after DMC greenlight ✅ 🔬 Interim data: ✔️ Reduced P. aeruginosa ✔️ Found in sputum ✔️ Well tolerated Next phase underway! 🔗 lnkd.in/efzbq89N

🚨 Progress update from Clarametyx Biosciences!

CMTX-101 for CF lung infections moves forward after DMC greenlight ✅

🔬 Interim data:
✔️ Reduced P. aeruginosa
✔️ Found in sputum
✔️ Well tolerated

Next phase underway!
🔗 lnkd.in/efzbq89N
City of Mason-EcoDev (@masonohecodev) 's Twitter Profile Photo

Proud to be a part of this great momentum in #MasonOH! Congrats, Genetesis, Cincinnati Inno Fire Award finalist! The first CardioFlux Imaging Institute in the #MasonLivingLab ups the standard of heart science. Your innovative #medtech is transforming heart care. CincyTech

CincyTech (@cincy_tech) 's Twitter Profile Photo

🎉 Congrats to our President & CEO, Emma Off, on being named to the 2025 Cincinnati Business Courier's #40Under40! Passionate about Cincinnati’s growth and cultural vibrancy, Emma generously shares her expertise and energy, from boardrooms to the arts to economic development.

🎉 Congrats to our President &amp; CEO, Emma Off, on being named to the 2025 <a href="/BusinessCourier/">Cincinnati Business Courier</a>'s #40Under40!

Passionate about Cincinnati’s growth and cultural vibrancy, Emma generously shares her expertise and energy, from boardrooms to the arts to economic development.
CincyTech (@cincy_tech) 's Twitter Profile Photo

Proud to spotlight our portfolio company Airway Therapeutics and CEO Dr. Marc Salzberg, featured on the Progress, Potential, and Possibilities podcast! Airway is pioneering biologics for severe respiratory diseases—starting with infants at risk for BPD. youtu.be/KJ58uya0Op0?si…

CincyTech (@cincy_tech) 's Twitter Profile Photo

At CincyTech, we're proud to support researchers turning bold ideas into real-world healthcare solutions. We joined Cincinnati Children's Innovation Ventures for a great panel on driving innovation from lab to life. 🧬💡 scienceblog.cincinnatichildrens.org/commercializin…

Enable Injections (@enableinjection) 's Twitter Profile Photo

We’re excited to announce the enFuse System has been approved by Brazilian Health Regulatory Agency (Agencia Nacional de Vigilancia Sanitaria or ANVISA)! . Read the full announcement here: bit.ly/45wJnmi #enFuse #drugdelivery #subcu

We’re excited to announce the enFuse System has been approved by Brazilian Health Regulatory Agency (Agencia Nacional de Vigilancia Sanitaria or ANVISA)! . 
Read the full announcement here: bit.ly/45wJnmi
 
#enFuse #drugdelivery #subcu
City of Mason-EcoDev (@masonohecodev) 's Twitter Profile Photo

#ICYMI Congratulations, CincyTech CEO, Emma Off! We value your continued partnership, and are proud to keep advancing #tech in our region with you. Here’s to more #tech growth in #MasonOH! #MasonLovesTech

CincyTech (@cincy_tech) 's Twitter Profile Photo

We are pleased to announce our sponsorship of #OhioVCFest25, September 16-17, at the Huntington Convention Center of Cleveland. Connect with leading VCs, angel investors, ambitious founders, and industry pioneers. 👉 Secure your spot: ohiovcfest.com

We are pleased to announce our sponsorship of #OhioVCFest25, September 16-17, at the Huntington Convention Center of Cleveland. 

Connect with leading VCs, angel investors, ambitious founders, and industry pioneers.

👉 Secure your spot: ohiovcfest.com
CincyTech (@cincy_tech) 's Twitter Profile Photo

Big congrats to Sam Bowman on being named CMO at Cart.com 🛒! After helping grow Cincy-based Amify, Sam now leads global marketing at Cart as it doubles bookings + launches new initiatives. Cincinnati talent making waves nationwide! 🌟 bizjournals.com/cincinnati/inn…

CincyTech (@cincy_tech) 's Twitter Profile Photo

We’re proud to share that Neucore Bio has secured a $350K NIH STTR Phase I award to develop the FiXE™ exosome platform for targeted RNA delivery to Schwann cells, potentially paving the way for a CMT1A therapy. neucorebio.com/neucore-bio-aw…

We’re proud to share that Neucore Bio has secured a $350K NIH STTR Phase I award to develop the FiXE™ exosome platform for targeted RNA delivery to Schwann cells, potentially paving the way for a CMT1A therapy. 

neucorebio.com/neucore-bio-aw…